Literature DB >> 8485915

Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes.

I C Roura-Mir1, L Alcalde, F Vargas, E Tolosa, G Obiols, M Foz, D Jaraquemada, R Pujol-Borrell.   

Abstract

Endocrine autoimmune disorders are mediated by T cell-dependent responses to organ-specific antigens, but the mechanisms initiating the process remain unknown. Lymphocytes which use the gamma delta heterodimer as T cell receptor (TCR) for antigen constitute a distinct subset of T cells whose function remains elusive. In order to investigate their possible involvement in endocrine autoimmunity we have determined the proportion of gamma delta T cells in the peripheral blood of 23 patients with type 1 (insulin-dependent) diabetes mellitus (type-1 DM) and 30 patients with autoimmune thyrotoxicosis (Graves' disease). T lymphocyte TCR expression was assessed by fluorescence-activated flow cytometry on peripheral blood mononuclear cells using MoAbs UCHT1 (CD3), TCR delta 1 (gamma delta TCR), WT31 and beta F1 (alpha beta TCR) and both the percentage of T cells expressing gamma delta and the ratio gamma delta/alpha beta were calculated. In the diabetic patients gamma delta cells were not significantly different from the control group (7.7 +/- 54% versus 8.0 +/- 5.5% of T cells, P NS). There was no relation between the proportion of gamma delta lymphocytes and the presence of islet cell antibodies (ICA) in the sera. The Graves' patients showed a tendency towards a higher proportion of gamma delta T lymphocytes than the controls (gamma delta/alpha beta ratios: 0.095 +/- 0.047 versus 0.063 +/- 0.022, P = 0.03). In 14 Graves' patients the number of gamma delta were measured in paired samples of peripheral and intrathyroidal lymphocytes, demonstrating an expansion of gamma delta within the thyroid glands (0.21 +/- 0.3 versus 0.095 +/- 0.047, P = 0.032). Immunohistochemical studies showed that gamma delta cells were scattered among the predominant alpha beta lymphocytes infiltrating the thyroid gland and that they account for 10% of intraepithelial lymphocytes. No relation was found between the increase of gamma delta lymphocytes and any clinical features.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8485915      PMCID: PMC1554822          DOI: 10.1111/j.1365-2249.1993.tb03394.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Developmentally ordered appearance of thymocytes expressing different T-cell antigen receptors.

Authors:  W L Havran; J P Allison
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

2.  Intestinal intraepithelial lymphocytes are a distinct set of gamma delta T cells.

Authors:  M Bonneville; C A Janeway; K Ito; W Haser; I Ishida; N Nakanishi; S Tonegawa
Journal:  Nature       Date:  1988-12-01       Impact factor: 49.962

3.  Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies.

Authors:  A Lucas-Martin; M Foz-Sala; I Todd; G F Bottazzo; R Pujol-Borrell
Journal:  J Clin Endocrinol Metab       Date:  1988-02       Impact factor: 5.958

4.  Immunochemical proof that a novel rearranging gene encodes the T cell receptor delta subunit.

Authors:  H Band; F Hochstenbach; J McLean; S Hata; M S Krangel; M B Brenner
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

5.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

6.  Induction of intercellular adhesion molecule-1 but not of lymphocyte function-associated antigen-3 in thyroid follicular cells.

Authors:  E Tolosa; C Roura; M Martí; A Belfiore; R Pujol-Borrell
Journal:  J Autoimmun       Date:  1992-02       Impact factor: 7.094

7.  Expression of intercellular adhesion molecule-1 in thyroid follicular cells in autoimmune, non-autoimmune and neoplastic diseases of the thyroid gland: discordance with HLA.

Authors:  E Tolosa; C Roura; M Catálfamo; M Martí; A Lucas-Martín; A Sanmartí; I Salinas; G Obiols; M Foz-Sala; R Pujol-Borrell
Journal:  J Autoimmun       Date:  1992-02       Impact factor: 7.094

8.  Interferon-gamma induces HLA-DR expression by thyroid epithelium.

Authors:  I Todd; R Pujol-Borrell; L J Hammond; G F Bottazzo; M Feldmann
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

9.  Increased T lymphocytes bearing the gamma-delta T cell receptor in subjects at high risk for insulin dependent diabetes.

Authors:  F P Lang; D A Schatz; B H Pollock; W J Riley; N K Maclaren; M Dumont-Driscoll; D J Barrett
Journal:  J Autoimmun       Date:  1991-12       Impact factor: 7.094

10.  Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system.

Authors:  V Groh; S Porcelli; M Fabbi; L L Lanier; L J Picker; T Anderson; R A Warnke; A K Bhan; J L Strominger; M B Brenner
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.

Authors:  Eric Champagne; Laurent O Martinez; Pierre Vantourout; Xavier Collet; Ronald Barbaras
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Contribution of alphabeta and gammadelta T cells to the generation of primary immunoglobulin G-driven autoimmune response in immunoglobulin- mu-deficient/lpr mice.

Authors:  Jane Seagal; Doron Melamed
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

4.  The gamma delta T cell repertoire in Graves' disease and multinodular goitre.

Authors:  R S McIntosh; N Tandon; A P Pickerill; R Davies; D Barnett; A P Weetman
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

5.  Gamma delta T cell receptor gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies.

Authors:  T P O'Hanlon; W A Messersmith; M C Dalakas; P H Plotz; F W Miller
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

6.  Infiltrating gamma/delta T-cell receptor-positive lymphocytes in Hashimoto's thyroiditis, Graves' disease and papillary thyroid cancer.

Authors:  F Paolieri; C Pronzato; M Battifora; N Fiorino; G W Canonica; M Bagnasco
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

7.  Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.

Authors:  E Robak; J Z Błoński; J Bartkowiak; H Niewiadomska; A Sysa-Jedrzejowska; T Robak
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

8.  An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves' disease.

Authors:  Katharine Gupta; Jane Estrella; Rohit Rajagopal; Praseetha Shanmugalingam; David Simmons
Journal:  Clin Case Rep       Date:  2017-06-19

9.  Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease.

Authors:  Giovanni Triolo; Antonina Accardo-Palumbo; Francesco Dieli; Francesco Ciccia; Angelo Ferrante; Ennio Giardina; Caterina Di Sano; Giuseppe Licata
Journal:  Arthritis Res Ther       Date:  2003-06-30       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.